Filing Details

Accession Number:
0001288123-11-000092
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-23 17:09:13
Reporting Period:
2011-12-21
Filing Date:
2011-12-23
Accepted Time:
2011-12-23 17:09:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098972 Agenus Inc AGEN Biological Products, (No Disgnostic Substances) (2836) 061562417
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377202 Shalini Sharp C/O Antigenics Inc.
162 Fifth Ave., Suite 900
New York NY 10010
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-12-21 3,087 $2.24 48,551 No 4 S Direct
Common Stock Disposition 2011-12-22 1,548 $2.19 47,003 No 4 S Direct
Common Stock Disposition 2011-12-23 795 $2.20 46,208 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the sale of shares sold to cover anticipated Federal, state and local tax withholding requirements on future stock award.